William J. Stromberg - 23 May 2023 Form 4 Insider Report for GE HealthCare Technologies Inc. (GEHC)

Role
Director
Signature
/s/ Frank R. Jimenez, General Counsel and Corporate Secretary, as attorney-in-fact
Issuer symbol
GEHC
Transactions as of
23 May 2023
Net transactions value
$0
Form type
4
Filing time
25 May 2023, 16:28:15 UTC
Previous filing
01 Mar 2023
Next filing
17 Nov 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GEHC Common Stock, par value $0.01 per share Award $0 +3,584 $0.000000 3,584 23 May 2023 Direct F1, F2
transaction GEHC Common Stock, par value $0.01 per share Award $0 +1,408 +39% $0.000000 4,992 23 May 2023 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Award of restricted stock units with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock, of which 100% will vest on the earlier of: (i) the date of GE HealthCare's next annual meeting of stockholders and (ii) May 23, 2024. Settlement of vested restricted stock units may be deferred by the director, in which case, settlement will occur pursuant to the director's applicable deferral election in accordance with GE HealthCare's Non-Employee Director Compensation and Benefits Plan.
F2 Each restricted stock unit and deferred stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock.
F3 Award of fully vested deferred stock units with respect to GE HealthCare common stock. The reporting person elected, in accordance with GE HealthCare's Non-Employee Director Compensation and Benefits Plan, to receive fully vested deferred stock units in lieu of 100% of the cash retainer awarded to the reporting person. Settlement will occur pursuant to the director's applicable deferral election.